Form D — Renue Life Sciences, Inc.
0002158207-26-000001 · filed Oct 14, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Renue Life Sciences, Inc.
- CIK
- 2158207
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 1030 BRITTAN AVE.
SAN CARLOS, CA 94070 - Phone
- 732.692.3259
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Samuel David Perli · Executive OfficerSan Carlos, CA Find on LinkedIn ↗
-
Phanidhar Kukutla · Executive OfficerSan Carlos, CA Find on LinkedIn ↗
-
Jean-Louis Lelogeais · DirectorSan Carlos, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗